To view this email as a web page, click here.
 
TOP NEW DRUGS
 
FDA okays targeted leukemia treatment
FDA recently approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Read more
 
FDA approves novel leukemia, hepatitis C drugs
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Read more
 
Blockbuster diabetes drug earns heart indication
A top-selling diabetes drug has gained a cardiovascular (CV) indication from FDA.
Read more
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.